Born in 2020, after four yours of dedicated work-work-work, we are happily surprised by being noted and invited to participate in not one, not two but three leading catalyst and accelerator programs at the same time. The Neolook plan is an original Royal Philips global business plan, so we knew it had potential. We did not foresee being picked up so soon, now being activated across three continents simultaneously. What is going on?
1: Techstars Abu Dhabi for Middle East
Neolook is selected for the Techstars program in Abu Dhabi named Anjal Z (Generation Z), a premier accelerator for the Middle East. From a selection of 164 companies, we got to the top 6. The program offers a performance based funding of a quarter of a million to localize our solution, set up shop and try-out with leading hospitals and official bodies like the Early Childhood Authority (ECA). We will dedicate a full article on Abu Dhabi’s Anjal Z later.
2: Founded PHX for Europe, Middle East & US
In addition to Techstars, we have also achieved success with Founded.in. The Founded PHX program is focused on the European, Middle East, and American markets. It is a Neolook driven track with focus on a Series A funding round, even going so far as to launch or carve out an extra two special purpose daughter companies.
3: ScaleNL for the US
First not making it due to a 11th position for a 10 seat cohort, we got a late night call from ScaleNL in the US: one seat fell free unexpectedly. Could it be for us on short notice? We said yes on the spot. The ScaleNL Accelerator is specifically designed for Dutch companies to expand to the US market. It provides access to crucial networks and investors, allowing us to increase our presence in the U.S. and pave the way for further growth. As the US is a make or brake market for Neolook, we take on the learning journey with an empty mind, a beginner’s mind. Point zero.
Expansions
These three unplanned events mark the threshold of the next phase of our internationalization beyond Europe. Our regulatory rigor such as MDR CE, to name one, plays a key role in this process, ensuring that we continue to meet the highest standards in delivering medical services for intensive care. So does the plan to work with established and renowned global business partners who live and know the daunting international medtech field. To deliver in intensive care means to deliver as part of a fully performing and regulated medtech delivery chain. Solid partners for solid scalable solutions.
How it relates to IZA – the Dutch Integral Healthcare Agreement
This international recognition stacks like Lego on our efforts within the Dutch Integral Care Agreement (Integraal Zorg Akkoord), where we strive for sustainable, affordable, and accessible healthcare. Our Dutch IZA plan includes the bundling of more countries and collaboration across borders. It is essential for a sustainable durable effort of healthcare transformation in the niche of neonatal and paediatric intensive care. To cooperate, share and work together as one. Our solutions contribute to the transformation of the healthcare sector as it is desperately needed, and we remain committed to continuous innovation that will improve care in the short ánd the long term. We are in the game, and in it to stay.
